RxDoctor Payments Data

Joaquin Balaguer, DPM

Podiatrist · Bayamon, PRNPI 1356311229

Payments from drug & device makers

What this record shows

This record is dominated by education: $4,932 of the $7,585 with a category attached, or 65.0%. Arthrex accounts for 61.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $2,819 and has fallen 82.5% since, to $494 in 2024.

$7,585in general payments, 2019–2025

Across 29 payments — averaging $261.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • RMC Orthopedic & Surgical, Inc.$1K
  • Trice Medical, Inc.$439
  • Voom Medical Devices, Inc.$343
  • Boston Scientific$244
  • Stryker$165
  • plus $481 from 6 others

What the payments were for

  • Travel & lodging$1,23716%
  • Food & beverage$1,41719%
  • Education$4,93265%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex13$4,650
RMC Orthopedic & Surgical, Inc.2$1,263
Trice Medical, Inc.2$439
Voom Medical Devices, Inc.1$343
Boston Scientific3$244
Stryker1$165
Amniox Medical, Inc.1$160
Medical Device Business Services, Inc.2$116
Kerecis Limited1$92
Organogenesis Inc.1$50
Smith+Nephew1$45
Novastep Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few podiatrist providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$20,132
Medicare patients
80
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Potassium344$9,117
Ammonium Lactate180$5,246
Ciclopirox66$4,766
Itraconazole54$3,482
Cefadroxil243$2,678
Terbinafine Hcl128$2,205
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip53$1,705
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav81$1,398
Mometasone Furoate34$1,199
Ketorolac Tromethamine43$998
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen98$979
Clindamycin Hcl61$771
Nabumetone65$658
Cephalexin52$560
Pregabalin21$261

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →